Moreover, it was reported that all HCC cases upregulated by NEDD4 showed low SPRY2 protein levels, suggesting that NEDD4 may mediate the degradation of SPRY2 and be involved in a range of biological processes such as HCC occurrence and metastasis [98]. This evidence concerns the gene SPRY2 and hepatocellular carcinoma.